DIFFERENT PROCESS in Slovenian translation

• drugačen postopek
• drugačen proces
• različnih procesnih
• različnimi postopki

Examples of using Different process in English and their translations into Slovenian

Ml dose of an AS03-containing vaccine containing HA from H1N1 manufactured using a different process in children aged 3 to 9 years.
Ml za odrasle cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, pri otrocih, starih od 3 do 9 let.

manufactured using a different process.
izdelanega po drugačnem postopku.

Clinical data with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process suggest that a single dose may be sufficient.
Klinični podatki s cepivom z AS03 z vsebnostjo HA iz H1N1v, pridobljenim z drugačnim postopkom, kažejo, da lahko zadošča en sam odmerek.

Clinical studies with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process currently provide.
Iz kliničnih študij, v katerih so uporabili cepivo z AS03 z vsebnostjo HA iz H1N1v, pridobljeno z drugačnim postopkom so trenutno na voljo.

Nictotinamide(Vitamin B3) 21mg- Has been known to be effective as a metabolic regulator in up to 60 different process in the human body,
Nictotinamide(vitamin B3) 21mg- Ali je bilo znano, da je učinkovita kot regulator metabolizma v do 60 drugačen proces v človeškem telesu,

We operate the different process to manufacture the lather products such as 3 coating lines,
Delujemo različen postopek za izdelavo Pena izdelke, kot so 3 premaz proge,

manufactured using a different process and on administration of half a dose of the same vaccine i. e.
izdelanega z uporabo drugačnega postopka, in polovičnega odmerka istega cepiva tj.

There are limited data available from clinical studies with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in adults aged over 60 years and very limited data
Malo je podatkov iz kliničnih študij s cepivom z AS03 z vsebnostjo HA iz H1N1v, pridobljenim z drugačnim postopkom, pri odraslih, starejših od 60 let, in zelo malo je podatkov pri odraslih,

with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in children aged less than 6 months.
cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, ni podatkov o varnosti in imunogenosti pri otrocih, starih manj kot 6 mesecev.

of an AS03-containing vaccine containing HA from H1N1 manufactured using a different process there was an increase in injection site reactions and general symptoms after the second
cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, so po drugem odmerku v primerjavi s prvim odmerkom opazili več reakcij na mestu injiciranja

no information on administration of the AS03-containing vaccine containing HA from H1N1v manufactured using a different process with any other vaccines than non-adjuvanted seasonal influenza vaccine.
prav tako ni podatkov o uporabi cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, z drugimi cepivi kot s sezonskim cepivom proti gripi brez adjuvansa.

Additional data on reactogenicity are available from clinical studies in healthy subjects of various age groups from 6 months of age upwards who received an AS03-containing vaccine containing HA from H1N1v manufactured using a different process.
Iz kliničnih študij pri zdravih preiskovancih različnih starostnih skupin od 6 mesecev starosti dalje, ki so prejeli cepivo z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, so na voljo dodatni podatki o reaktogenosti.

Immunogenicity data obtained at three weeks after administration of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in clinical studies suggest that a single dose may be sufficient.
Podatki o imunogenosti, dobljeni tri tedne po uporabi cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, v kliničnih študijah kažejo, da morda lahko zadošča en sam odmerek.

Immunogenicity data obtained at three weeks after administration of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in clinical studies suggest that dosing may be in accordance with the recommendations for adults.
Podatki o imunogenosti, dobljeni tri tedne po uporabi cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, v kliničnih študijah kažejo, da je odmerjanje lahko v skladu s priporočili za odrasle.

One dose of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Indonesia/05/2005 manufactured using a different process administered after one or two doses of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Vietnam/1194/2004 manufactured using a different process.
En odmerek cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA iz A/Indonesia/05/2005, izdelanega po drugačnem postopku, uporabljen po enem ali dveh odmerkih cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA iz A/Vietnam/1194/2004, izdelanega po drugačnem postopku.

reactions reported in the clinical trials, the following have been reported during post-marketing experience with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process.
opisanih v kliničnih preskušanjih, so bili po pridobitvi dovoljenja za promet s cepivom z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom opisani tudi naslednji neželeni učinki.

whereas we are now seeing a different process, a kind of competitiveness surrounding interest rate cuts.
smo sedaj priča drugačnemu procesu, nekakšni konkurenčnosti, ki se nanaša na zmanjševanje obrestnih mer.

Preliminary immunogenicity data obtained with an AS03-containing vaccine containing HA from H1N1v manufactured using a different process in a limited number of children aged 6-35 months show that there is a further immune response to a second dose of 0.25 ml administered after an interval of three weeks.
Preliminarni podatki o imunogenosti, pridobljeni s cepivom z AS03 z vsebnostjo HA iz H1N1v, pridobljenim z drugačnim postopkom, pri majhnem številu otrok, starih od 6 do 35 mesecev, kažejo dodaten imunski odziv na drugi odmerek 0,25 ml, uporabljen po presledku treh tednov.

Ml doses(21 days apart) of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process there was an increase in injection site reactions and general symptoms after the second dose compared to the first dose particularly in rates
Ml odmerka za odrasle(21 dni narazen) cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, so opazili več reakcij na mestu injiciranja in splošnih simptomov,

Data obtained on co-administration of an AS03-containing vaccine containing HA from H1N1v manufactured using a different process with non-adjuvanted seasonal influenza vaccine(Fluarix,
Podatki, dobljeni pri sočasni uporabi cepiva z AS03 z vsebnostjo HA iz H1N1v, pridobljenega z drugačnim postopkom, s cepivom proti sezonski gripi brez adjuvansa(Fluarix,